Unknown OBSERVATIONAL NCT04248348

Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients (MeTHOS)

Metaxa's Thromboprophylaxis Program in Oncological & Surgical Patients

Sponsor: Metaxa Hospital

Interventions Low Molecular Weight Heparin

Updated 5 times since 2020 Last updated: Jan 28, 2020 Started: Dec 1, 2018 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Solid Cancer and Thrombosis and is currently ongoing. Metaxa Hospital leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Recruiting
Feb 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Metaxa Hospital

Data source: Metaxa Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Piraeus, Greece